Hubert Schrezenmeier to Young Adult
This is a "connection" page, showing publications Hubert Schrezenmeier has written about Young Adult.
Connection Strength
0.079
-
Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing. J Infect Dis. 2021 03 03; 223(5):796-801.
Score: 0.025
-
Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica. 2014 May; 99(5):922-9.
Score: 0.015
-
Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial. Stem Cell Res Ther. 2018 08 09; 9(1):213.
Score: 0.005
-
Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects. Haematologica. 2018 09; 103(9):1527-1534.
Score: 0.005
-
First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012. Am J Hematol. 2018 05; 93(5):643-648.
Score: 0.005
-
Human leukocyte antigen-E mismatch is associated with better hematopoietic stem cell transplantation outcome in acute leukemia patients. Haematologica. 2017 11; 102(11):1947-1955.
Score: 0.005
-
Clinical benefit of eculizumab in patients with no transfusion history in the International Paroxysmal Nocturnal Haemoglobinuria Registry. Intern Med J. 2017 Sep; 47(9):1026-1034.
Score: 0.005
-
Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective Study. PLoS One. 2017; 12(1):e0169512.
Score: 0.005
-
Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantation. Haematologica. 2017 04; 102(4):796-803.
Score: 0.005
-
Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II. Ann Hematol. 2017 Feb; 96(2):171-181.
Score: 0.005